303 related articles for article (PubMed ID: 34831379)
21. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
22. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
[TBL] [Abstract][Full Text] [Related]
23. Cas9-Mediated Genome Engineering in Drosophila melanogaster.
Housden BE; Perrimon N
Cold Spring Harb Protoc; 2016 Sep; 2016(9):. PubMed ID: 27587786
[TBL] [Abstract][Full Text] [Related]
24. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
[TBL] [Abstract][Full Text] [Related]
25. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
26. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).
Rodríguez-Rodríguez DR; Ramírez-Solís R; Garza-Elizondo MA; Garza-Rodríguez ML; Barrera-Saldaña HA
Int J Mol Med; 2019 Apr; 43(4):1559-1574. PubMed ID: 30816503
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos.
Hennig SL; Owen JR; Lin JC; Young AE; Ross PJ; Van Eenennaam AL; Murray JD
Sci Rep; 2020 Dec; 10(1):22309. PubMed ID: 33339870
[TBL] [Abstract][Full Text] [Related]
28. Damage-induced regeneration of the intestinal stem cell pool through enteroblast mitosis in the Drosophila midgut.
Tian A; Morejon V; Kohoutek S; Huang YC; Deng WM; Jiang J
EMBO J; 2022 Oct; 41(19):e110834. PubMed ID: 35950466
[TBL] [Abstract][Full Text] [Related]
29. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
[TBL] [Abstract][Full Text] [Related]
30. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas gene therapy.
Zhang B
J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
[TBL] [Abstract][Full Text] [Related]
32. Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells.
Prat F; Toutain J; Boutin J; Amintas S; Cullot G; Lalanne M; Lamrissi-Garcia I; Moranvillier I; Richard E; Blouin JM; Dabernat S; Moreau-Gaudry F; Bedel A
Stem Cell Reports; 2020 Sep; 15(3):677-693. PubMed ID: 32795423
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing.
Chaverra-Rodriguez D; Macias VM; Hughes GL; Pujhari S; Suzuki Y; Peterson DR; Kim D; McKeand S; Rasgon JL
Nat Commun; 2018 Aug; 9(1):3008. PubMed ID: 30068905
[TBL] [Abstract][Full Text] [Related]
34. Spatial and temporal control of gene manipulation in Drosophila via drug-activated Cas9 nucleases.
Huynh N; Wang S; King-Jones K
Insect Biochem Mol Biol; 2020 May; 120():103336. PubMed ID: 32105778
[TBL] [Abstract][Full Text] [Related]
35. Coupling Cas9 to artificial inhibitory domains enhances CRISPR-Cas9 target specificity.
Aschenbrenner S; Kallenberger SM; Hoffmann MD; Huck A; Eils R; Niopek D
Sci Adv; 2020 Feb; 6(6):eaay0187. PubMed ID: 32076642
[TBL] [Abstract][Full Text] [Related]
36. Marker-free genome editing in Ustilago trichophora with the CRISPR-Cas9 technology.
Huck S; Bock J; Girardello J; Gauert M; Pul Ü
RNA Biol; 2019 Apr; 16(4):397-403. PubMed ID: 29996713
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.
Haapaniemi E; Botla S; Persson J; Schmierer B; Taipale J
Nat Med; 2018 Jul; 24(7):927-930. PubMed ID: 29892067
[TBL] [Abstract][Full Text] [Related]
38. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas9-Based Genome Editing in Plants.
Zhang Y; Ma X; Xie X; Liu YG
Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
[TBL] [Abstract][Full Text] [Related]
40. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
